{"ORPHApacket":[{"ORPHApacketID":"119","date":"2019-12-06 08:32:13","version":"1.3.1 \/ 4.1.7 [2019-11-24] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"119","Name":[{"lang":"en","label":"Autosomal recessive limb-girdle muscular dystrophy type 2E"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_119","DisorderType":[{"Name":[{"lang":"en","label":"Disease"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_377788"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"Qualitative or quantitative defects of beta-sarcoglycan"}],"ORPHA":"207063","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_207063"},{"Name":[{"lang":"en","label":"Autosomal recessive limb-girdle muscular dystrophy"}],"ORPHA":"102015","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_102015"},{"Name":[{"lang":"en","label":"Neuromuscular disease with dilated cardiomyopathy"}],"ORPHA":"217610","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_217610"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Definition"}],"Contents":"A subtype of autosomal recessive limb girdle muscular dystrophy characterized by a childhood to adolescent onset of progressive pelvic- and shoulder-girdle muscle weakness, particularly affecting the pelvic girdle (adductors and flexors of hip). Usually the knees are the earliest and most affected muscles. In advanced stages, involvement of the shoulder girdle (resulting in scapular winging) and the distal muscle groups are observed. Calf hypertrophy, cardiomyopathy, respiratory impairment, tendon contractures, scoliosis, and exercise-induced myoglobinuria may be observed."}],"ExternalReferenceList":[{"count":"1","ExternalReference":[{"Source":"OMIM","Reference":"604286","DisorderMappingRelation":[{"id":"21527","Name":[{"lang":"en","label":"E (exact mapping (the terms and the concepts are equivalent))"}]}]}]}],"AverageAgeOfOnsetList":[{"count":"2","AverageAgeOfOnset":[{"Name":[{"lang":"en","label":"Adolescent"}]},{"Name":[{"lang":"en","label":"Childhood"}]}]}],"TypeOfInheritanceList":[{"count":"1","TypeOfInheritance":[{"Name":[{"lang":"en","label":"Autosomal recessive"}]}]}],"SynonymList":[{"count":"3","Synonym":[{"lang":"en","label":"Beta-sarcoglycanopathy"},{"lang":"en","label":"LGMD2E"},{"lang":"en","label":"Limb-girdle muscular dystrophy due to beta-sarcoglycan deficiency"}]}],"DisorderGeneAssociationList":[{"count":"1","DisorderGeneAssociation":[{"Gene":[{"Name":[{"lang":"en","label":"sarcoglycan beta"}],"Symbol":"SGCB","ExternalReferenceList":[{"count":"2","ExternalReference":[{"Source":"HGNC","Reference":"10806"},{"Source":"OMIM","Reference":"600900"}]}]}],"DisorderGeneAssociationType":[{"OrphaNumber":"317343","Name":[{"lang":"en","label":"Disease-causing germline mutation(s) in"}]}]}]}],"HPODisorderAssociationList":[{"count":"13","HPODisorderAssociation":[{"HPOId":"HP:0000750","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0000750","HPOTerm":"Delayed speech and language development","HPOFrequency":[{"ORPHA":"453312","Name":[{"lang":"en","label":"Frequent (79-30%)"}]}]},{"HPOId":"HP:0002058","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0002058","HPOTerm":"Myopathic facies","HPOFrequency":[{"ORPHA":"453312","Name":[{"lang":"en","label":"Frequent (79-30%)"}]}]},{"HPOId":"HP:0002136","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0002136","HPOTerm":"Broad-based gait","HPOFrequency":[{"ORPHA":"453312","Name":[{"lang":"en","label":"Frequent (79-30%)"}]}]},{"HPOId":"HP:0002355","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0002355","HPOTerm":"Difficulty walking","HPOFrequency":[{"ORPHA":"453312","Name":[{"lang":"en","label":"Frequent (79-30%)"}]}]},{"HPOId":"HP:0002515","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0002515","HPOTerm":"Waddling gait","HPOFrequency":[{"ORPHA":"453312","Name":[{"lang":"en","label":"Frequent (79-30%)"}]}]},{"HPOId":"HP:0003198","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0003198","HPOTerm":"Myopathy","HPOFrequency":[{"ORPHA":"453312","Name":[{"lang":"en","label":"Frequent (79-30%)"}]}]},{"HPOId":"HP:0003236","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0003236","HPOTerm":"Elevated serum creatine phosphokinase","HPOFrequency":[{"ORPHA":"453312","Name":[{"lang":"en","label":"Frequent (79-30%)"}]}]},{"HPOId":"HP:0003391","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0003391","HPOTerm":"Gowers sign","HPOFrequency":[{"ORPHA":"453312","Name":[{"lang":"en","label":"Frequent (79-30%)"}]}]},{"HPOId":"HP:0003557","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0003557","HPOTerm":"Increased variability in muscle fiber diameter","HPOFrequency":[{"ORPHA":"453312","Name":[{"lang":"en","label":"Frequent (79-30%)"}]}]},{"HPOId":"HP:0003749","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0003749","HPOTerm":"Pelvic girdle muscle weakness","HPOFrequency":[{"ORPHA":"453312","Name":[{"lang":"en","label":"Frequent (79-30%)"}]}]},{"HPOId":"HP:0008981","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0008981","HPOTerm":"Calf muscle hypertrophy","HPOFrequency":[{"ORPHA":"453312","Name":[{"lang":"en","label":"Frequent (79-30%)"}]}]},{"HPOId":"HP:0001638","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0001638","HPOTerm":"Cardiomyopathy","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0002913","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0002913","HPOTerm":"Myoglobinuria","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]}]}],"HPODisorderSetStatus":[{"ValidationStatus":"y"}]}]}